Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome

2004 ◽  
Vol 31 ◽  
pp. 12-17 ◽  
Author(s):  
Richard M Stone ◽  
D.Gary Gilliland ◽  
Amy D Klion
Keyword(s):  
Growth Factor ◽  
Hypereosinophilic Syndrome ◽  
Growth Factor Receptor ◽  
Platelet Derived Growth Factor ◽  
Idiopathic Hypereosinophilic Syndrome ◽  
Receptor Inhibition

Platelet-derived growth factor receptor inhibition reduces allograft arteriosclerosis of heart and aorta in cholesterol-fed rabbits

2003 ◽  
Vol 75 (3) ◽  
pp. 334-339 ◽  
Author(s):  
Roope K. Sihvola ◽  
Jussi M. Tikkanen ◽  
Rainer Krebs ◽  
Eva M. Aaltola ◽  
Elisabeth Buchdunger ◽  
...  
Keyword(s):  
Growth Factor ◽  
Growth Factor Receptor ◽  
Platelet Derived Growth Factor ◽  
Receptor Inhibition

scholarly journals Occurrence of Balínt Syndrome in a Patient with Hypereosinophilic Syndrome

2020 ◽  
Author(s):  
Philipp Klocke ◽  
Anna Whalen-Browne ◽  
Elliot Hepworth ◽  
Mohamed Panju
Keyword(s):  
Growth Factor ◽  
Hypereosinophilic Syndrome ◽  
Growth Factor Receptor ◽  
Platelet Derived Growth Factor ◽  
Ocular Motor ◽  
Visually Guided ◽  
Optic Ataxia ◽  
First Case ◽  
Motor Apraxia ◽  
Voluntary Saccades

Balínt Syndrome is an acquired disorder manifesting in the inability to recognize several objects at once (simultagnosia), inaccurate visually guided limb movements despite intact motor function (optic ataxia) and the inability to make accurate voluntary saccades to visual targets despite demonstrating unrestricted range of eye movements (ocular motor apraxia). Here we report the first case of a patient presenting with Balínt Syndrome caused by a platelet-derived growth factor receptor A mutation (PDGFRA)-induced Hypereosinophilic Syndrome (HES).

Sign in / Sign up

Export Citation Format

Share Document